Health Claims on Botanical Substances Prohibited Pending Commission Evaluation: Case C–386/23, Novel Nutriology [2025] ECLI:EU:C:2025:304
The Court of Justice of the European Union (CJEU) ruled that health claims relating to botanical substances cannot be used in commercial advertising without prior authorisation, even during the prolonged suspension of the European Commission’s evaluation process. In Case C-386/23, Novel Nutriology,...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
|
| Series: | European Journal of Risk Regulation |
| Subjects: | |
| Online Access: | https://www.cambridge.org/core/product/identifier/S1867299X2510038X/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The Court of Justice of the European Union (CJEU) ruled that health claims relating to botanical substances cannot be used in commercial advertising without prior authorisation, even during the prolonged suspension of the European Commission’s evaluation process. In Case C-386/23, Novel Nutriology, the Court clarified that Article 10(1) and (3) of Regulation (EC) No 1924/2006 (Nutrition and Health Claims Regulation, NHCR) maintains its prohibition on unauthorised health claims regardless of administrative delays in the assessment process. The judgment provides guidance for food business operators marketing botanical products and highlights ongoing regulatory challenges in balancing consumer protection with commercial interests. This case note examines the Court’s reasoning, situates the decision within broader CJEU case law, and explores potential regulatory reforms to address the persistent impasse surrounding botanical health claims in European Union (EU) food law. |
|---|---|
| ISSN: | 1867-299X 2190-8249 |